Latest news
Liraglutide combination products using Stevanato Group pen gain European approval - Drug Store NewsDrug Store News · Fri, 07 Aug 2026 12:30:51 GMTStevanato Group (NYSE: STVN) targets 26.8% 2026 EBITDA margin - Stock TitanStock Titan · Thu, 06 Aug 2026 20:00:36 GMTTD Cowen Maintains Stevanato Group(STVN.US) With Buy Rating, Maintains Target Price $25 - MoomooMoomoo · Thu, 06 Aug 2026 03:23:38 GMTStevanato Group SpA Revenue Breakdown – DUS:87N - TradingViewTradingView · Thu, 06 Aug 2026 02:23:35 GMTStevanato Group Details Mid-2026 Performance and Risk Landscape in Unaudited Interim Report - theglobeandmail.comtheglobeandmail.com · Wed, 05 Aug 2026 21:15:13 GMTSage Park’s Craftech Acquires Balda C. Brewer from Stevanato Group - Medical Product OutsourcingMedical Product Outsourcing · Wed, 05 Aug 2026 16:07:33 GMTStevanato Group (STVN) Stock Faces Cash Strain Despite Margin Gains - simplywall.stsimplywall.st · Wed, 05 Aug 2026 03:55:45 GMTStevanato Group SpA (STVN) (Q2 2026) Earnings Call Highlights: Biologics Surge and Alina ... - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 21:02:38 GMT